Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/15/1585   
Active ingredient: Sirolimus
Indication: Treatment of beta thalassaemia intermedia and major
Sponsor: Rare Partners srl Impresa Sociale
Corso Magenta 31, 20123 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/142/15 (2015)9506 of 14/12/2015